Japan has been leveraging different policy tools to rein in drug expenditures, and that is scaring foreign pharmas away. The country is seeing “trends of a drug lag,” as approvals decrease, Yasushi ...
Dublin, Aug. 29, 2025 (GLOBE NEWSWIRE) -- The "Japan Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033" has been added to ResearchAndMarkets.com's offering.
The Japanese government has approved the country’s first gene therapeutic drug, Collategene, designed to treat critical limb ischemia. It’s inventor, Morishita, talks about overcoming obstacles to ...
Greater attention to this frequently unaddressed aspect of Japanese life is needed as the nation aims to assert its stature as a global leader. Japanese Prime Minister Fumio Kishida will welcome world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback